Beta Drugs
add_icon

Beta Drugs

1,671.40
-19.20
(-1.14%)
Market Cap
₹- Cr
PE Ratio
-
Volume
2,328.00
Day High - Low
₹1,734.90 - ₹1,605.00
52W High-Low
₹2,300.00 - ₹1,501.00
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
- Cr
EPS
-
PB Ratio
-
Book Value
195.25
EBITDA
-
Dividend Yield
- %
Industry
Healthcare
ROE Growth %
-
Debt to Equity
-
Forecast For
Actual

Company News

View All News
Caret
positive
Beta Drugs has received approval to list its equity shares on the main board after migrating from the SME Emerge platform. This migration represents a significant milestone for the company, allowing it to access broader investor base and enhanced market visibility.
positive
Beta Drugs Gains Access to Mexico's Oncology MarketMay 05, 2025
Beta Drugs has completed the COFEPRIS approval process for its oncology formulation and API manufacturing plants. This regulatory approval grants the company access to Mexico's oncology market, valued at USD 1.3 billion.
positive
Beta Drugs: Healthquad Fund II Invests Rs 117 Crore for Minority StakeNov 27, 2024
Healthquad Fund II, a Singapore-based investment fund, has acquired a minority stake in Beta Drugs by investing Rs 117 crore. Beta Drugs plans to use the funds to accelerate growth and aims to become one of the top five oncology companies in India within five years. The company currently offers various cancer treatments and operates in 46 countries.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
790.15
-
#1 -
-
-
-
-
34.61
699.20
-
#1 -
-
-
-
-
43.29
64.57
-
#1 -
-
-
-
-
21.03
554.80
-
#1 -
-
-
-
-
37.85
28,850.00
-
#1 -
-
-
-
-
39.24
42.05
-
#1 -
-
-
-
-
41.15
54.60
-
#1 -
-
-
-
-
42.72
5,001.00
-
#1 -
-
-
-
-
43.40
414.10
-
#1 -
-
-
-
-
43.97
26.95
-
#1 -
-
-
-
-
41.68
Growth Rate
Revenue Growth
-
Net Income Growth
-
Cash Flow Change
-
ROE
-
ROCE
-
EBITDA Margin (Avg.)
-

Yearly Financial Results

Annual Financials
2018
2019
2020
2021
2022
2023
2024
2025
TTM
Revenue
51
66
91
117
185
228
297
369
0
Expenses
41
54
73
91
141
174
236
288
0
EBITDA
10
12
18
25
44
54
61
81
0
Operating Profit %
19 %
18 %
20 %
21 %
23 %
23 %
20 %
21 %
0 %
Depreciation
2
3
4
7
7
10
10
13
0
Interest
1
1
3
2
2
2
3
7
0
Profit Before Tax
7
8
12
16
34
41
49
57
0
Tax
0
-0
3
4
10
10
12
15
0
Net Profit
7
8
9
12
25
31
36
42
0
EPS in ₹
7.82
9.30
9.79
12.20
25.82
31.95
37.90
42.02
0.00

Balance Sheet

Balance Sheet
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
50
83
107
118
158
198
254
436
Fixed Assets
13
18
44
40
55
63
65
89
Current Assets
32
43
56
68
97
128
178
331
Capital Work in Progress
1
15
0
3
0
0
0
0
Investments
0
0
0
0
0
0
0
0
Other Assets
35
50
63
75
103
136
190
347
Total Liabilities
50
83
107
118
158
198
254
436
Current Liabilities
14
32
37
33
49
63
85
103
Non Current Liabilities
3
9
13
16
17
13
12
136
Total Equity
33
41
57
69
92
123
157
197
Reserve & Surplus
24
32
48
59
83
113
148
187
Share Capital
9
9
10
10
10
10
10
10

Cash Flow

Cash Flow
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
12
-9
2
5
7
2
10
118
Investing Activities
-11
-21
-15
-6
-22
-19
-14
-36
Operating Activities
17
0
8
19
30
23
31
36
Financing Activities
5
12
9
-8
-1
-3
-8
118

Share Holding

% Holding
Aug 2017
Sept 2017
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Nov 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Nov 2025
Promoter
93.78 %
93.78 %
66.68 %
66.68 %
66.68 %
66.71 %
66.71 %
66.71 %
66.71 %
66.71 %
66.73 %
66.73 %
66.73 %
66.73 %
66.73 %
66.73 %
66.73 %
66.73 %
66.73 %
66.73 %
66.73 %
66.73 %
66.73 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.32 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.02 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
21.63 %
21.88 %
22.72 %
22.86 %
22.86 %
22.59 %
22.61 %
22.60 %
22.52 %
22.24 %
22.37 %
22.33 %
22.35 %
21.96 %
21.70 %
21.63 %
21.60 %
21.81 %
21.75 %
21.81 %
21.78 %
Others
6.22 %
6.22 %
11.68 %
11.44 %
10.60 %
10.43 %
10.43 %
10.70 %
10.68 %
10.69 %
10.75 %
11.03 %
10.90 %
10.60 %
10.91 %
11.31 %
11.56 %
11.64 %
11.66 %
11.45 %
11.51 %
11.45 %
11.49 %
No of Share Holders
0
0
0
0
540
507
542
675
762
1,296
1,407
1,424
1,451
1,722
1,928
2,116
2,323
2,567
2,793
2,882
3,045
3,139
3,184

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
30 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2024 1,693.10 1,676.00
06 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Nov 2024 1,971.30 1,944.15
12 Nov 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
12 Nov 2024 1,892.10 2,178.40
21 Dec 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
21 Dec 2024 2,192.00 2,060.05
26 Mar 2025 BONUS Bonus
1:20
26 Mar 2025 1,850.00 1,935.00
15 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
15 May 2025 1,750.35 1,854.00
06 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Nov 2025 1,855.00 1,743.15

Technical Indicators